marketcaparena
Search

    CYRX

    Cryoport, Inc.

    Company overview

    Market capitalization
    $880.28M
    Employees
    684
    Latest publication
    2026-09-29
    About Cryoport, Inc.

    Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells cryogenic freezers, cryogenic dewars, and related ancillary accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport Elite; Cryoport Express Cryogenic HV3 Shipping System; Smartpak Condition Monitoring System and Tec4Med, an IoT-based monitoring solutions; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services; MVE Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ4 20192019-12-31 · USDQ1 20162016-03-31 · USDQ2 20152015-06-30 · USDQ1 20152015-03-31 · USDQ4 20142014-12-31 · USDQ3 20142014-09-30 · USDQ2 20142014-06-30 · USDQ1 20142014-03-31 · USD
    Total Revenue9,242,066USD1,555,545USD1,431,063USD1,198,544USD975,188USD825,000USD936,588USD834,826USD
    Cost Of Revenue4,309,757USD973,738USD943,151USD828,465USD740,651USD600,042USD597,233USD691,676USD
    Gross Profit4,932,309USD581,807USD487,912USD370,079USD234,537USD224,958USD339,355USD143,150USD
    Research Development1,069,585USD144,478USD77,724USD85,005USD99,052USD89,279USD79,244USD79,542USD
    Selling General Administrative2,132,865USD1,814,421USD1,141,748USD1,978,091USD1,492,732USD1,510,708USD1,427,850USD1,338,170USD
    Selling And Marketing Expenses2,608,210USD1,247,026USD884,609USD—————
    Total Operating Expenses5,810,660USD3,205,925USD2,104,081USD2,063,096USD1,591,784USD1,599,987USD1,507,094USD1,417,712USD
    Operating Income-878,351USD-2,624,118USD-1,616,169USD-1,693,017USD-1,357,247USD-1,375,029USD-1,167,739USD-1,274,562USD
    Interest Income445,880USD———————
    Interest Expense445,876USD81,194USD303,800USD242,678USD48,605USD7,854USD1,128,878USD157,673USD
    Net Interest Income-445,876USD———————
    Income Before Tax-896,574USD-2,710,184USD-1,920,944USD-1,937,132USD-1,407,758USD-1,384,759USD-2,295,664USD-1,440,310USD
    Income Tax Expense50,965USD86,066USD3,320USD244,115USD50,511USD9,730USD1,600USD1,600USD
    Tax Provision50,965USD———————
    Net Income-947,539USD-2,710,184USD-1,924,264USD-1,937,132USD-1,407,758USD-1,384,759USD-2,297,264USD-1,441,910USD
    Net Income From Continuing Ops-947,539USD-7,059,911USD-1,924,264USD-7,026,913USD-1,407,758USD-1,384,759USD-2,297,264USD-19,565,426USD
    Ebit-450,698USD-2,624,118USD-1,617,144USD-1,694,454USD-1,357,247USD-1,375,029USD-1,167,739USD-1,282,637USD
    Ebitda374,353USD-2,551,214USD-1,571,471USD-1,651,742USD-1,307,207USD-1,324,983USD-1,112,599USD-1,229,236USD
    Depreciation And Amortization825,051USD72,904USD45,673USD42,712USD50,040USD50,046USD55,140USD53,401USD
    Reconciled Depreciation825,051USD72,904USD45,673USD42,712USD50,040USD50,046USD55,140USD53,401USD
    Total Other Income Expense Net-18,223USD-86,066USD-304,775USD-244,115USD-50,511USD-9,730USD-1,127,925USD-165,748USD
    Net Income Applicable To Common Shares-947,539USD-12,057,597USD-6,607,102USD-12,196,533USD-1,995,972USD-3,183,660USD-3,066,773USD-19,565,426USD
    Minority Interest—0USD0USD0USD0USD0USD0USD0USD
    Discontinued Operations—0USD0USD0USD0USD0USD0USD0USD
    Non Operating Income Net Other——-975USD—-1,906USD-1,876USD953USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20092009-12-31 · USDFY 20082008-12-31 · USDFY 20072007-12-31 · USDFY 20062006-12-31 · USDFY 20052005-12-31 · USDFY 20042004-12-31 · USDFY 20032003-12-31 · USD
    Total Revenue117,956USD35,124USD67,103USD152,298USD152,298USD271,429USD84,285USD
    Cost Of Revenue717,710USD546,152USD176,939USD315,650USD315,650USD499,650USD424,805USD
    Gross Profit-599,754USD-511,028USD-109,836USD-163,352USD-163,352USD-228,221USD-340,520USD
    Research Development284,847USD297,378USD87,857USD254,487USD254,487USD98,698USD61,000USD
    Selling General Administrative3,312,635USD2,387,287USD1,899,228USD1,023,088USD1,023,088USD622,797USD—
    Total Operating Expenses3,597,482USD2,684,665USD1,986,455USD1,277,572USD1,277,572USD721,495USD491,912USD
    Operating Income-4,197,236USD-3,195,693USD-2,096,291USD-1,440,924USD-1,440,924USD-949,716USD-832,432USD
    Interest Expense7,028,684USD2,693,383USD228,368USD80,377USD0USD85,768USD67,791USD
    Income Before Tax-5,649,961USD-16,703,551USD-2,324,659USD-1,521,301USD-1,521,301USD-1,037,310USD-1,001,693USD
    Income Tax Expense1,600USD1,600USD1,600USD800USD800USD800USD800USD
    Net Income-5,651,561USD-16,705,151USD-2,326,259USD-1,522,101USD-1,522,101USD-1,038,110USD-1,002,493USD
    Ebit1,378,727USD-14,010,167USD-2,096,291USD-1,440,924USD-1,440,924USD-949,716USD-933,902USD
    Ebitda1,528,820USD-13,928,183USD-1,985,072USD-1,352,171USD-1,352,171USD-857,120USD-841,954USD
    Depreciation And Amortization150,093USD81,984USD111,219USD88,753USD88,753USD92,596USD91,948USD
    Total Other Income Expense Net-1,452,725USD-13,507,858USD-228,368USD-80,377USD80,377USD-87,594USD-169,261USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Assets763,609,000USD764,989,000USD774,328,000USD699,844,000USD699,844,000USD703,492,000USD701,765,000USD852,341,000USD
    Intangible Assets138,721,000USD138,082,000USD141,254,000USD145,414,000USD145,414,000USD170,464,000USD175,815,000USD178,388,000USD
    Other Current Assets6,147,000USD8,419,000USD5,289,000USD115,534,000USD115,534,000USD11,574,000USD10,658,000USD11,075,000USD
    Total Liab268,620,000USD262,351,000USD261,057,000USD301,033,000USD301,033,000USD301,594,000USD283,193,000USD452,246,000USD
    Total Stockholder Equity494,989,000USD502,638,000USD513,271,000USD398,811,000USD398,811,000USD401,898,000USD418,572,000USD400,095,000USD
    Other Current Liab17,007,000USD12,980,000USD10,864,000USD40,338,000USD40,338,000USD16,941,000USD14,426,000USD13,745,000USD
    Common Stock50,000USD50,000USD50,000USD50,000USD50,000USD50,000USD49,000USD49,000USD
    Capital Stock44,325,000USD42,325,000USD40,325,000USD38,325,000USD36,325,000USD34,325,000USD32,324,000USD30,324,000USD
    Retained Earnings-699,428,000USD-688,884,000USD-675,235,000USD-769,156,000USD-769,156,000USD-757,175,000USD-738,498,000USD-739,303,000USD
    Good Will22,137,000USD22,400,000USD22,409,000USD20,960,000USD20,960,000USD51,660,000USD54,057,000USD52,384,000USD
    Cash272,912,000USD250,494,000USD255,811,000USD36,102,000USD36,102,000USD45,289,000USD44,665,000USD46,458,000USD
    Cash And Short Term Investments403,634,000USD411,208,000USD421,314,000USD244,031,000USD244,031,000USD261,749,000USD272,666,000USD427,142,000USD
    Total Current Assets470,535,000USD476,174,000USD484,843,000USD411,276,000USD411,276,000USD341,571,000USD350,337,000USD501,986,000USD
    Total Current Liabilities224,867,000USD219,018,000USD30,749,000USD74,030,000USD74,030,000USD64,563,000USD61,439,000USD59,885,000USD
    Current Deferred Revenue2,314,000USD943,000USD1,447,000USD1,774,000USD1,774,000USD1,106,000USD1,091,000USD1,317,000USD
    Net Debt-42,423,000USD-19,776,000USD-24,951,000USD206,566,000USD206,566,000USD205,414,000USD188,701,000USD358,143,000USD
    Short Term Debt189,609,000USD189,812,000USD4,554,000USD18,476,000USD18,476,000USD20,348,000USD20,728,000USD20,018,000USD
    Short Long Term Debt185,549,000USD185,257,000USD——14,475,000USD14,441,000USD14,424,000USD14,354,000USD
    Short Long Term Debt Total230,489,000USD230,718,000USD230,860,000USD242,668,000USD242,668,000USD250,703,000USD233,366,000USD404,601,000USD
    Long Term Debt1,027,000USD1,087,000USD186,090,000USD185,832,000USD185,333,000USD185,033,000USD184,866,000USD356,923,000USD
    Short Term Investments130,722,000USD160,714,000USD165,503,000USD207,929,000USD207,929,000USD216,460,000USD228,001,000USD380,684,000USD
    Net Receivables39,004,000USD33,359,000USD34,914,000USD28,371,000USD28,371,000USD45,778,000USD43,461,000USD40,160,000USD
    Inventory21,750,000USD23,188,000USD23,326,000USD23,340,000USD23,340,000USD22,470,000USD23,552,000USD23,609,000USD
    Accounts Payable15,937,000USD15,283,000USD13,884,000USD13,442,000USD13,442,000USD26,168,000USD25,194,000USD24,805,000USD
    Property Plant Equipment Net129,104,000USD125,168,000USD123,457,000USD119,583,000USD119,583,000USD136,027,000USD118,394,000USD116,337,000USD
    Property Plant Equipment Gross129,104,000USD174,651,000USD123,457,000USD119,771,000USD119,583,000USD181,892,000USD118,394,000USD116,337,000USD
    Accumulated Other Comprehensive Income-3,212,000USD-3,483,000USD-4,068,000USD-15,738,000USD-15,738,000USD-20,929,000USD-16,376,000USD-29,189,000USD
    Common Stock Shares Outstanding49,897,817shares49,759,264shares50,125,268shares50,257,112shares49,947,012shares49,616,806shares49,417,757shares49,345,644shares
    Non Current Assets Total293,074,000USD288,815,000USD289,485,000USD288,568,000USD288,568,000USD361,921,000USD351,428,000USD350,355,000USD
    Non Current Liabilities Total43,753,000USD43,333,000USD230,308,000USD227,003,000USD227,003,000USD237,031,000USD221,754,000USD392,361,000USD
    Non Current Liabilities Other1,293,000USD1,073,000USD3,338,000USD3,195,000USD1,933,000USD4,145,000USD5,590,000USD5,127,000USD
    Non Currrent Assets Other2,046,000USD2,092,000USD2,097,000USD1,997,000USD1,997,000USD2,902,000USD1,493,000USD1,668,000USD
    Net Working Capital245,668,000USD257,156,000USD454,094,000USD459,341,000USD337,246,000USD277,008,000USD288,898,000USD442,101,000USD
    Unclassified Current Liabilities-185,549,000USD-185,257,000USD——-14,475,000USD-14,441,000USD-14,424,000USD-14,354,000USD
    Unclassified Non Current Liabilities41,433,000USD41,173,000USD40,880,000USD37,976,000USD39,737,000USD47,853,000USD31,298,000USD30,311,000USD
    Unclassified Equity1,153,254,000USD1,152,630,000USD1,152,199,000USD1,145,330,000USD1,147,330,000USD1,145,627,000USD1,141,073,000USD1,138,214,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets764,989,000USD703,492,000USD957,744,000USD1,038,746,000USD1,112,970,000USD552,405,000USD135,873,000USD56,620,097USD
    Intangible Assets138,082,000USD170,464,000USD194,382,000USD191,009,000USD201,427,000USD213,908,000USD5,178,000USD137,220USD
    Other Current Assets8,419,000USD11,574,000USD10,077,000USD9,317,000USD8,804,000USD11,928,000USD1,097,000USD752,269USD
    Total Liab262,351,000USD301,594,000USD468,721,000USD482,908,000USD471,142,000USD169,707,000USD9,592,000USD18,073,532USD
    Total Stockholder Equity502,638,000USD401,898,000USD489,023,000USD555,838,000USD641,828,000USD382,698,000USD126,281,000USD38,546,565USD
    Other Current Liab12,980,000USD16,941,000USD12,441,000USD9,458,000USD9,912,000USD7,441,000USD1,904,000USD1,262,478USD
    Common Stock50,000USD50,000USD49,000USD48,000USD50,000USD40,000USD37,000USD30,319USD
    Capital Stock42,325,000USD34,325,000USD26,324,000USD18,323,000USD10,325,000USD2,884,000USD37,340USD30,319USD
    Retained Earnings-688,884,000USD-757,175,000USD-642,419,000USD-542,832,000USD-467,541,000USD-192,013,000USD-159,320,000USD-140,988,484USD
    Good Will22,400,000USD51,660,000USD108,403,000USD151,117,000USD146,954,000USD145,282,000USD11,000,000USD—
    Cash250,494,000USD45,289,000USD46,346,000USD36,595,000USD139,101,000USD36,873,000USD47,235,000USD37,327,125USD
    Cash And Short Term Investments411,208,000USD261,749,000USD456,755,000USD523,323,000USD628,799,000USD93,317,000USD94,296,000USD47,258,093USD
    Total Current Assets476,174,000USD341,571,000USD535,112,000USD604,176,000USD693,516,000USD147,157,000USD102,965,000USD51,774,542USD
    Total Current Liabilities219,018,000USD64,563,000USD45,610,000USD40,851,000USD42,645,000USD35,020,000USD5,461,000USD3,061,381USD
    Current Deferred Revenue943,000USD1,106,000USD1,308,000USD439,000USD547,000USD445,000USD368,000USD66,315USD
    Net Debt-19,776,000USD205,414,000USD369,657,000USD399,313,000USD287,954,000USD94,046,000USD-42,434,000USD-22,559,198USD
    Short Term Debt189,812,000USD20,348,000USD5,806,000USD3,908,000USD3,603,000USD2,290,000USD691,000USD23,191USD
    Short Long Term Debt185,257,000USD14,441,000USD149,000USD128,000USD————
    Short Long Term Debt Total230,718,000USD250,703,000USD416,003,000USD435,908,000USD427,055,000USD130,919,000USD4,801,000USD14,767,931USD
    Long Term Debt1,087,000USD185,033,000USD379,888,000USD407,063,000USD405,257,000USD116,256,000USD—14,711,580USD
    Short Term Investments160,714,000USD216,460,000USD410,409,000USD486,728,000USD489,698,000USD56,444,000USD47,061,000USD9,930,968USD
    Net Receivables33,359,000USD45,778,000USD42,074,000USD43,858,000USD39,412,000USD31,377,000USD7,098,000USD3,543,666USD
    Inventory23,188,000USD22,470,000USD26,206,000USD27,678,000USD16,501,000USD10,535,000USD474,000USD220,514USD
    Accounts Payable15,283,000USD26,168,000USD26,055,000USD27,046,000USD28,583,000USD24,844,000USD2,498,000USD1,709,397USD
    Property Plant Equipment Net125,168,000USD136,027,000USD117,511,000USD90,480,000USD69,704,000USD44,080,000USD16,293,000USD4,357,498USD
    Property Plant Equipment Gross174,651,000USD181,892,000USD154,098,000USD90,480,000USD49,029,000USD44,080,000USD16,293,376USD4,357,498USD
    Accumulated Other Comprehensive Income-3,483,000USD-20,929,000USD-26,065,000USD-34,549,000USD-1,243,000USD5,376,000USD-45,000USD3,153USD
    Common Stock Shares Outstanding50,071,665shares48,737,377shares48,987,295shares45,927,591shares45,927,591shares38,582,432shares33,394,285shares28,210,648shares
    Non Current Assets Total288,815,000USD361,921,000USD422,632,000USD434,570,000USD419,454,000USD405,248,000USD32,908,000USD4,845,555USD
    Non Current Liabilities Total43,333,000USD237,031,000USD423,111,000USD442,057,000USD428,497,000USD134,687,000USD4,131,000USD15,012,151USD
    Non Current Liabilities Other1,073,000USD4,145,000USD10,098,000USD5,128,000USD1,027,000USD176,000USD——
    Non Currrent Assets Other2,092,000USD2,902,000USD1,680,000USD1,017,000USD950,000USD1,978,000USD437,000USD350,837USD
    Net Working Capital257,156,000USD277,008,000USD489,502,000USD563,325,000USD650,871,000USD112,137,000USD97,504,083USD48,713,161USD
    Unclassified Current Liabilities-185,257,000USD-14,441,000USD——————
    Unclassified Non Current Liabilities41,173,000USD47,853,000USD33,125,000USD19,809,000USD17,168,000USD12,197,000USD4,110,000USD—
    Unclassified Equity1,152,630,000USD1,145,627,000USD1,131,134,000USD1,114,848,000USD1,100,237,000USD566,411,000USD285,571,660USD179,471,258USD
    Other Assets——1USD1,964,000USD1,369,000USD16,022,000USD437,000USD350,837USD
    Other Liab———10,057,000USD5,045,000USD6,058,000USD21,000USD267,415USD
    Net Tangible Assets———195,437,000USD293,447,000USD379,854,000USD110,103,000USD38,409,345USD
    Unclassified Non Current Assets—————-16,022,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-9,432,000USD-11,644,000USD-3,254,000USD-11,981,000USD-11,981,000USD-18,677,000USD805,000USD-77,989,000USD
    Depreciation6,402,000USD6,355,000USD6,415,000USD7,296,000USD7,646,000USD7,894,000USD7,836,000USD7,558,000USD
    Stock Based Compensation2,395,000USD2,431,000USD2,526,000USD3,700,000USD3,064,000USD4,413,000USD4,838,000USD4,997,000USD
    Other Non Cash Items5,072,000USD6,058,000USD-2,181,000USD6,403,000USD-1,980,000USD3,694,000USD-17,277,000USD62,974,000USD
    Change To Account Receivables-5,733,000USD1,301,000USD-1,883,000USD-6,723,000USD778,000USD-3,074,000USD-2,633,000USD1,121,000USD
    Change To Inventory1,319,000USD-97,000USD-421,000USD638,000USD-2,305,000USD536,000USD284,000USD1,319,000USD
    Change In Working Capital1,457,000USD-2,281,000USD-1,318,000USD-10,133,000USD-1,065,000USD-2,804,000USD3,606,000USD-5,565,000USD
    Total Cash From Operating Activities3,735,000USD919,000USD2,188,000USD-7,345,000USD-4,342,000USD-5,480,000USD447,000USD-8,025,000USD
    Capital Expenditures-10,282,000USD-4,944,000USD-4,282,000USD-4,351,000USD-4,078,000USD-5,641,000USD-1,498,000USD-5,770,000USD
    Free Cash Flow-6,547,000USD-4,025,000USD-2,094,000USD-11,696,000USD-8,420,000USD-11,121,000USD-1,051,000USD-13,795,000USD
    Investments29,000,000USD5,000,000USD14,306,000USD230,039,000USD5,922,000USD3,479,000USD153,570,000USD13,321,000USD
    Total Cashflows From Investing Activities18,718,000USD56,000USD14,306,000USD230,039,000USD5,922,000USD3,479,000USD153,570,000USD13,321,000USD
    Net Borrowings-144,000USD-145,000USD-146,000USD-14,552,000USD-192,000USD-130,000USD-155,312,000USD—
    Total Cash From Financing Activities85,000USD-2,153,000USD-2,868,000USD-15,864,000USD-189,000USD2,012,000USD-155,291,000USD-8,764,000USD
    Change In Cash22,418,000USD-5,317,000USD12,395,000USD207,314,000USD-9,187,000USD624,000USD-1,793,000USD-3,205,000USD
    Begin Period Cash Flow250,494,000USD255,811,000USD243,416,000USD36,102,000USD45,289,000USD44,665,000USD46,458,000USD49,663,000USD
    End Period Cash Flow272,912,000USD250,494,000USD255,811,000USD243,416,000USD36,102,000USD45,289,000USD44,665,000USD46,458,000USD
    Other Cashflows From Investing Activities-301,000USD523,000USD-829,000USD-910,000USD-910,000USD-422,000USD-6,478,000USD-1,980,000USD
    Unclassified Operating Cash Flow-2,159,000USD——-2,630,000USD————
    Dividends Paid—-2,000,000USD-6,000,000USD——-6,000,000USD-4,000,000USD—
    Sale Purchase Of Stock—-2,007,000USD-3,745,000USD-4,259,000USD————
    Other Cashflows From Financing Activities—2,000,000USD6,000,000USD3,000USD-189,000USD6,000,000USD4,000,000USD9,000USD
    Unclassified Investing Cash Flow——5,111,000USD5,261,000USD4,988,000USD6,063,000USD7,976,000USD7,750,000USD
    Unclassified Financing Cash Flow——1,023,000USD2,944,000USD—2,142,000USD—-8,773,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income78,301,000USD-114,756,000USD-99,587,000USD-37,333,000USD-275,528,000USD-32,693,000USD-18,332,000USD-9,555,601USD
    Depreciation27,712,000USD30,757,000USD27,487,000USD22,765,000USD20,247,000USD9,869,000USD2,415,000USD857,939USD
    Stock Based Compensation11,032,000USD19,704,000USD22,808,000USD20,082,000USD15,345,000USD8,916,000USD16,524,000USD5,478,625USD
    Other Non Cash Items-111,931,000USD56,581,000USD49,734,000USD20,111,000USD1,236,000USD437,000USD1,042,000USD899,410USD
    Change To Account Receivables-6,527,000USD-4,149,000USD3,673,000USD-4,137,000USD-7,270,000USD-2,617,000USD-3,596,000USD-1,958,405USD
    Change To Inventory-2,185,000USD3,252,000USD1,508,000USD-14,204,000USD-5,979,000USD1,322,000USD-253,000USD-105,718USD
    Change In Working Capital-13,694,000USD-8,609,000USD780,000USD-28,423,000USD-6,963,000USD-2,253,000USD-2,973,000USD-1,486,668USD
    Total Cash From Operating Activities-8,580,000USD-16,323,000USD-757,000USD-1,851,000USD8,126,000USD-14,866,000USD-1,324,000USD-3,352,380USD
    Capital Expenditures-19,505,000USD-17,254,000USD-44,900,000USD-24,197,000USD-25,007,000USD-9,669,000USD-5,409,000USD-2,960,603USD
    Free Cash Flow-28,085,000USD-33,577,000USD-45,657,000USD-26,048,000USD-16,881,000USD-24,535,000USD-6,733,000USD-6,312,983USD
    Investments59,589,000USD176,815,000USD57,929,000USD-59,681,000USD-438,707,000USD-9,503,000USD-37,200,959USD-9,923,619USD
    Total Cashflows From Investing Activities250,323,000USD176,815,000USD36,045,000USD-59,681,000USD-469,254,000USD-382,312,000USD-62,927,000USD-12,884,222USD
    Net Borrowings-15,035,000USD-164,321,000USD-25,276,000USD-3,262,000USD36,611,000USD110,882,000USD-23,191USD14,696,880USD
    Total Cash From Financing Activities-21,074,000USD-161,531,000USD-23,798,000USD-39,174,000USD564,342,000USD385,585,000USD74,150,269USD38,531,092USD
    Dividends Paid-8,000,000USD-8,000,000USD-8,000,000USD-8,000,000USD-8,196,000USD-2,844,000USD——
    Sale Purchase Of Stock-10,011,000USD0USD23,596,000USD-37,960,000USD8,196,000USD2,844,000USD74,173,460USD20,471,056USD
    Change In Cash205,205,000USD-1,057,000USD9,751,000USD-102,506,000USD102,228,000USD-10,362,000USD9,907,645USD22,284,936USD
    Begin Period Cash Flow45,289,000USD46,346,000USD36,595,000USD139,101,000USD36,873,000USD47,235,000USD37,327,125USD15,042,189USD
    End Period Cash Flow250,494,000USD45,289,000USD46,346,000USD36,595,000USD139,101,000USD36,873,000USD47,234,770USD37,327,125USD
    Other Cashflows From Investing Activities-3,066,000USD-4,326,000USD-5,139,000USD3,000,000USD-6,665,000USD-363,891,000USD-73,000USD-46,574USD
    Other Cashflows From Financing Activities8,000,000USD8,000,000USD1,478,000USD8,000,000USD297,974,000USD357,495,000USD5,363,000USD5,732,499USD
    Unclassified Investing Cash Flow213,305,000USD21,580,000USD28,155,000USD21,197,000USD——-20,244,041USD—
    Unclassified Financing Cash Flow3,972,000USD2,790,000USD-15,596,000USD2,048,000USD229,757,000USD-82,792,000USD-5,363,000USD-2,369,343USD
    Issuance Of Capital Stock——0USD248,911,000USD518,736,000USD265,385,000USD68,810,718USD17,813,293USD
    Unclassified Operating Cash Flow——-1,979,000USD—253,789,000USD———
    Change To Liabilities———-7,424,000USD-65,000USD7,388,000USD1,211,719USD800,704USD
    Cash And Cash Equivalents Changes————103,214,000USD-11,593,000USD9,899,294USD22,284,936USD
    Exchange Rate Changes———————-9,554USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31GeographyAmericas34,958,000USD0001104659-26-055513
    Q1 2026Quarterly · 2026-03-31GeographyAsia Pacific3,889,000USD0001104659-26-055513
    Q1 2026Quarterly · 2026-03-31GeographyEMEA8,951,000USD0001104659-26-055513
    Q1 2026Quarterly · 2026-03-31ProductBiologistics Solutions21,668,000USD0001104659-26-055513
    Q1 2026Quarterly · 2026-03-31ProductBiostorage Bioservices5,230,000USD0001104659-26-055513
    Q1 2026Quarterly · 2026-03-31ProductOther972,000USD0001104659-26-055513
    Q1 2026Quarterly · 2026-03-31ProductProduct20,900,000USD0001104659-26-055513
    Q1 2026Quarterly · 2026-03-31SegmentLife Sciences Products20,363,000USD0001104659-26-055513
    Q1 2026Quarterly · 2026-03-31SegmentLife Sciences Services27,435,000USD0001104659-26-055513
    Q4 2025Quarterly · 2025-12-31GeographyAmericas32,685,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyAsia Pacific5,678,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyEMEA7,087,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductBiologistics Solutions20,304,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductBiostorage Bioservices4,701,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductProduct20,445,000USDLegacy provider
    FY 2025Yearly · 2025-12-31GeographyAmericas131,260,000USD0001104659-26-024180
    FY 2025Yearly · 2025-12-31GeographyAsia Pacific19,783,000USD0001104659-26-024180
    FY 2025Yearly · 2025-12-31GeographyEMEA25,134,000USD0001104659-26-024180
    FY 2025Yearly · 2025-12-31ProductBiologistics Solutions78,137,000USD0001104659-26-024180
    FY 2025Yearly · 2025-12-31ProductBiostorage Bioservices18,360,000USD0001104659-26-024180
    FY 2025Yearly · 2025-12-31ProductOther1,739,000USD0001104659-26-024180
    FY 2025Yearly · 2025-12-31ProductProduct79,680,000USD0001104659-26-024180
    FY 2025Yearly · 2025-12-31SegmentOther1,739,000USD0001104659-26-024180
    FY 2025Yearly · 2025-12-31SegmentReportable Segment Aggregation Before Other Operating — Life Sciences Products75,149,000USD0001104659-26-024180
    FY 2025Yearly · 2025-12-31SegmentReportable Segment Aggregation Before Other Operating — Life Sciences Services101,028,000USD0001104659-26-024180
    Q3 2025Quarterly · 2025-09-30GeographyAmericas33,143,000USD0001104659-25-107640
    Q3 2025Quarterly · 2025-09-30GeographyAsia Pacific4,456,000USD0001104659-25-107640
    Q3 2025Quarterly · 2025-09-30GeographyEMEA6,634,000USD0001104659-25-107640
    Q3 2025Quarterly · 2025-09-30ProductBiologistics Solutions19,428,000USD0001104659-25-107640
    Q3 2025Quarterly · 2025-09-30ProductBiostorage Bioservices4,830,000USD0001104659-25-107640
    Q3 2025Quarterly · 2025-09-30ProductProduct19,975,000USD0001104659-25-107640
    Q3 2025Quarterly · 2025-09-30SegmentReportable Segment Aggregation Before Other Operating — Life Sciences Products18,736,000USD0001104659-25-107640
    Q3 2025Quarterly · 2025-09-30SegmentReportable Segment Aggregation Before Other Operating — Life Sciences Services25,497,000USD0001104659-25-107640
    Q2 2025Quarterly · 2025-06-30GeographyAmericas33,237,000USD0001558370-25-011127
    Q2 2025Quarterly · 2025-06-30GeographyAsia Pacific6,384,000USD0001558370-25-011127
    Q2 2025Quarterly · 2025-06-30GeographyEMEA5,833,000USD0001558370-25-011127
    Q2 2025Quarterly · 2025-06-30ProductBiologistics Solutions19,874,000USD0001558370-25-011127
    Q2 2025Quarterly · 2025-06-30ProductBiostorage Bioservices4,495,000USD0001558370-25-011127
    Q2 2025Quarterly · 2025-06-30ProductProduct21,085,000USD0001558370-25-011127
    Q2 2025Quarterly · 2025-06-30SegmentReportable Segment Aggregation Before Other Operating — Life Science Supply Chain Solutions25,818,000USD0001558370-25-011127
    Q2 2025Quarterly · 2025-06-30SegmentReportable Segment Aggregation Before Other Operating — Life Science Systems19,636,000USD0001558370-25-011127
    Q1 2025Quarterly · 2025-03-31GeographyAmericas32,195,000USD0001104659-26-055513
    Q1 2025Quarterly · 2025-03-31GeographyAsia Pacific3,265,000USD0001104659-26-055513
    Q1 2025Quarterly · 2025-03-31GeographyEMEA5,580,000USD0001104659-26-055513
    Q1 2025Quarterly · 2025-03-31ProductBiologistics Solutions18,531,000USD0001104659-26-055513
    Q1 2025Quarterly · 2025-03-31ProductBiostorage Bioservices4,334,000USD0001104659-26-055513
    Q1 2025Quarterly · 2025-03-31ProductOther395,000USD0001104659-26-055513
    Q1 2025Quarterly · 2025-03-31ProductProduct18,175,000USD0001104659-26-055513
    Q1 2025Quarterly · 2025-03-31SegmentLife Sciences Products17,827,000USD0001104659-26-055513
    Q1 2025Quarterly · 2025-03-31SegmentLife Sciences Services23,213,000USD0001104659-26-055513
    Q4 2024Quarterly · 2024-12-31GeographyAmericas29,596,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyAsia Pacific4,970,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyEMEA6,886,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductBiologistics Solutions17,479,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductBiostorage Bioservices3,997,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductProduct19,976,000USDLegacy provider
    FY 2024Yearly · 2024-12-31GeographyAmericas113,545,000USD0001104659-26-024180
    FY 2024Yearly · 2024-12-31GeographyAsia Pacific16,202,000USD0001104659-26-024180
    FY 2024Yearly · 2024-12-31GeographyEMEA27,022,000USD0001104659-26-024180
    FY 2024Yearly · 2024-12-31ProductBiologistics Solutions67,019,000USD0001104659-26-024180
    FY 2024Yearly · 2024-12-31ProductBiostorage Bioservices15,025,000USD0001104659-26-024180
    FY 2024Yearly · 2024-12-31ProductOther1,181,000USD0001104659-26-024180
    FY 2024Yearly · 2024-12-31ProductProduct74,725,000USD0001104659-26-024180
    FY 2024Yearly · 2024-12-31SegmentOther1,181,000USD0001104659-26-024180
    FY 2024Yearly · 2024-12-31SegmentReportable Segment Aggregation Before Other Operating — Life Sciences Products71,434,000USD0001104659-26-024180
    FY 2024Yearly · 2024-12-31SegmentReportable Segment Aggregation Before Other Operating — Life Sciences Services85,335,000USD0001104659-26-024180
    Q3 2024Quarterly · 2024-09-30GeographyAmericas27,839,000USD0001104659-25-107640
    Q3 2024Quarterly · 2024-09-30GeographyAsia Pacific4,275,000USD0001104659-25-107640
    Q3 2024Quarterly · 2024-09-30GeographyEMEA6,203,000USD0001104659-25-107640
    Q3 2024Quarterly · 2024-09-30ProductBiologistics Solutions16,955,000USD0001104659-25-107640
    Q3 2024Quarterly · 2024-09-30ProductBiostorage Bioservices3,976,000USD0001104659-25-107640
    Q3 2024Quarterly · 2024-09-30ProductProduct17,386,000USD0001104659-25-107640
    Q3 2024Quarterly · 2024-09-30SegmentReportable Segment Aggregation Before Other Operating — Life Sciences Products17,016,000USD0001104659-25-107640
    Q3 2024Quarterly · 2024-09-30SegmentReportable Segment Aggregation Before Other Operating — Life Sciences Services21,301,000USD0001104659-25-107640
    Q2 2024Quarterly · 2024-06-30GeographyAmericas29,420,000USD0001558370-25-011127
    Q2 2024Quarterly · 2024-06-30GeographyAsia Pacific3,756,000USD0001558370-25-011127
    Q2 2024Quarterly · 2024-06-30GeographyEMEA6,533,000USD0001558370-25-011127
    Q2 2024Quarterly · 2024-06-30ProductBiologistics Solutions16,628,000USD0001558370-25-011127
    Q2 2024Quarterly · 2024-06-30ProductBiostorage Bioservices3,524,000USD0001558370-25-011127
    Q2 2024Quarterly · 2024-06-30ProductProduct19,557,000USD0001558370-25-011127
    Q2 2024Quarterly · 2024-06-30SegmentReportable Segment Aggregation Before Other Operating — Life Science Supply Chain Solutions21,567,000USD0001558370-25-011127
    Q2 2024Quarterly · 2024-06-30SegmentReportable Segment Aggregation Before Other Operating — Life Science Systems18,142,000USD0001558370-25-011127
    Q1 2024Quarterly · 2024-03-31SegmentReportable Segment Aggregation Before Other Operating — Life Science Supply Chain Solutions19,874,000USD0001558370-25-007012
    Q1 2024Quarterly · 2024-03-31SegmentReportable Segment Aggregation Before Other Operating — Life Science Systems17,417,000USD0001558370-25-007012
    FY 2023Yearly · 2023-12-31GeographyAmericas117,895,000USD0001104659-26-024180
    FY 2023Yearly · 2023-12-31GeographyAsia Pacific23,117,000USD0001104659-26-024180
    FY 2023Yearly · 2023-12-31GeographyEMEA27,650,000USD0001104659-26-024180
    FY 2023Yearly · 2023-12-31ProductBiologistics Solutions65,905,000USD0001104659-26-024180
    FY 2023Yearly · 2023-12-31ProductBiostorage Bioservices13,589,000USD0001104659-26-024180
    FY 2023Yearly · 2023-12-31ProductOther1,827,000USD0001104659-26-024180
    FY 2023Yearly · 2023-12-31ProductProduct89,168,000USD0001104659-26-024180
    FY 2023Yearly · 2023-12-31SegmentOther1,827,000USD0001104659-26-024180
    FY 2023Yearly · 2023-12-31SegmentReportable Segment Aggregation Before Other Operating — Life Sciences Products87,474,000USD0001104659-26-024180
    FY 2023Yearly · 2023-12-31SegmentReportable Segment Aggregation Before Other Operating — Life Sciences Services81,188,000USD0001104659-26-024180
    FY 2022Yearly · 2022-12-31GeographyAmericas128,209,000USD0001558370-25-002509
    FY 2022Yearly · 2022-12-31GeographyAsia Pacific42,155,000USD0001558370-25-002509
    FY 2022Yearly · 2022-12-31GeographyEMEA66,913,000USD0001558370-25-002509
    FY 2022Yearly · 2022-12-31ProductBiologistics Solutions124,798,000USD0001558370-25-002509
    FY 2022Yearly · 2022-12-31ProductBiostorage Bioservices9,081,000USD0001558370-25-002509
    FY 2022Yearly · 2022-12-31ProductProduct103,398,000USD0001558370-25-002509

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.